SPOTLIGHT ASSET GROUP, INC. Relmada Therapeutics, Inc. Transaction History

SPOTLIGHT ASSET GROUP, INC. portfolio value:

$140,000
portfolio value

SPOTLIGHT ASSET GROUP, INC. quarter portfolio value change:

+41.24%
quarter

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -33.92% -10.26K shares -653K $37.02 20K
Q3 2021 share 0.00% 0 shares -176K $26.21 30.26K
Q2 2021 share Increase +23.20% 5.7K shares 104K $32.01 30.26K
Q1 2021 share Increase +8.17% 1.85K shares 137K $35.21 24.56K
Q4 2020 share Increase 0.00% 22.70K shares 728K $32.07 22.70K